72 studies found for:    EUCLID
Show Display Options
Rank Status Study
1 Active, not recruiting A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
Condition: Peripheral Artery Disease
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
2 Completed Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).
Conditions: Epstein-Barr Virus Infections;   Lymphoproliferative Disorders
Intervention: Biological: Intravenous injection of EBV specific CTLs
3 Terminated Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Intervention: Device: Dermal - Living Skin Replacement (Dermal - LSR)
4 Withdrawn Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone, Plus Systemic Dexamethasone
Condition: Pain
Interventions: Drug: Ropivacaine;   Drug: Dexamethasone;   Drug: placebo
5 Completed Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
Conditions: Brain Tumor;   Brain Tumor, Recurrent;   Brain Neoplasm;   Brain Cancer;   Glioblastoma Multiforme;   Recurrent Glioblastoma Multiforme
Intervention: Device: AutoLITT system
6 Terminated
Has Results
Effects of Coenzyme Q10 (CoQ) in Parkinson Disease
Condition: Parkinson Disease
Interventions: Drug: Coenzyme Q10 with vitamin E;   Drug: placebo with vitamin E
7 Terminated
Has Results
Interventional Management of Stroke (IMS) III Trial
Condition: Stroke
Interventions: Drug: IV rt-PA alone;   Other: endovascular therapy
8 Completed Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir
9 Completed
Has Results
Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis
Conditions: Tinea Pedis;   Athlete's Foot
Interventions: Drug: NAFT-500;   Drug: Placebo 2-weeks;   Drug: Naftin 1%;   Drug: Placebo 4-weeks
10 Completed
Has Results
Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris
Conditions: Tinea Cruris;   Jock Itch
Interventions: Drug: NAFT-500;   Drug: Placebo
11 Completed
Has Results
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension
Condition: Hypertension
Interventions: Drug: Olmesartan medoxomil;   Drug: Amlodipine;   Drug: Hydrochlorothiazide
12 Not yet recruiting Investigating the Immune Response to 4CMenB in Infants
Condition: Meningitis
Intervention: Biological: 4CMenB
13 Active, not recruiting Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
Condition: Moderate to Severe Plaque Psoriasis
Interventions: Drug: 210 mg brodalumab;   Drug: 140 mg brodalumab;   Drug: ustekinumab;   Drug: placebo
14 Terminated
Has Results
A Study for Adults With Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: LY2525623 Intravenous;   Drug: LY2525623 Subcutaneous;   Drug: Placebo Intravenous;   Drug: Placebo Subcutaneous
15 Completed Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions: Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Hematopoietic/Lymphoid Cancer;   Nodal Marginal Zone B-cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Small Lymphocytic Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Splenic Marginal Zone Lymphoma;   Waldenström Macroglobulinemia
Interventions: Drug: bortezomib;   Drug: fludarabine phosphate;   Biological: rituximab
16 Completed Differences in Timely Cancer Diagnosis in African American and Caucasian Patients With Newly Diagnosed Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Other: medical chart review;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Other: survey administration
17 Completed Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Interventions: Drug: Davunetide;   Drug: Placebo
18 Completed
Has Results
LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)
Condition: Psoriasis Vulgaris
Interventions: Drug: Calcipotriol plus betamethasone;   Drug: Betamethasone-17,21-dipropionate;   Drug: Calcipotriene;   Drug: Topical suspension vehicle
19 Recruiting The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions
Conditions: Allergic Rhinitis;   Asthma;   Allergic Conjunctivitis
Intervention: Drug: Allergen(Tree, Grass, Weeds)
20 Completed
Has Results
Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%
Condition: Acne Vulgaris
Interventions: Drug: Adapalene lotion 0.1%;   Drug: Adapalene Lotion Vehicle

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years